Jun 11, 2026

Vitamins & Supplements M&A Update – June 2026

Evolving Wellness Priorities Accelerate Vitamins & Supplements M&A

Capstone Partners latest Vitamins & Supplements M&A Report shares that merger and acquisition (M&A) activity in the sector has increased year-over-year (YOY) to date as operators have continued to capitalize on resilient consumer health and wellness tailwinds. High-growth niches including Women’s Lifecycle Preventative Solutions have offered the Vitamins & Supplements sector new long-term opportunities for product expansion and inorganic growth. Meanwhile, the Contract Manufacturing subsector has seen heightened acquisition activity given its insulation from brand risk amid the sensitive consumer spending backdrop.

Evolving consumer preferences, particularly the growing influence of the Women’s Health segment, have continued to reshape demand patterns and product expectations across the Vitamins & Supplements M&A market in 2026. This shift has occurred alongside an expansion of research and development (R&D) and healthcare access focused on closing the women’s health gap. Women’s lifecycle product development has evolved to include condition‑specific formulations, personalized nutrition, and preventative wellness offerings designed to integrate seamlessly into consumers’ daily routines. Within these expanded portfolios, hormonal and fertility products have emerged as key areas of focus, particularly for menopause-, prenatal-, and postnatal-related applications. Heightened consumer awareness of the benefits these supplements offer in managing common menopausal symptoms has driven this prioritization. Moreover, consumption patterns have shifted from reactive towards proactive, preventative methodologies as educational resources and dialogue across the Women’s Health space has grown. Similarly, the Contract Manufacturing or Contract Development and Manufacturing Organization (CDMO) segment has emerged as a strategically attractive hot spot within the Vitamins & Supplements market. Contract manufacturer use cases have grown as sector brands have looked to outsource manufacturing capabilities to meet rising demand and expand access to innovative, user-friendly vitamins and supplements formats like powders, liquids, chewables, and gummies. Outsourcing formulation, flavorings, manufacturing, and packaging enables sector participants to accelerate speed to market and avoid operational burdens associated with costly facility build‑outs, workforce management, and regulatory compliance.

Strategic buyers have commanded the majority of sector deal volume to date, comprising 61.1% of transactions. Both private (+30% YOY) and public (+12.5%) strategic acquirers have accelerated dealmaking year to date (YTD), aimed at gaining a presence in emerging pockets of the market. Financial sponsor M&A activity has rebounded more sharply, up to 14 transactions YTD. Private equity (PE) platform formations have also continued to expand, signaling renewed PE confidence in establishing scalable footholds in the sector. M&A valuation multiples in the Vitamins & Supplements sector have moderated as buyers have recalibrated pricing to more normalized levels in the post-pandemic landscape.

“Vitamins & Supplements M&A is a market that has matured—strategics aren’t just buying growth, they’re buying capability and category relevance. Women’s health has moved from a niche segment to a strategic priority, with feminine care brands attracting significant interest from acquirers seeking authentic, consumer-trusted platforms,” said Capstone Managing Director Lisa Tolliver, the lead contributor in the newly released report.

Also included in this report:

  • A breakdown of the Contract Manufacturing segment and how that has become a critical pocket of Vitamins & Supplements M&A market.
  • Insights on notable transactions in the sector and the underlying rationale.
  • A breakdown of how public companies have performed against sector peers.

Capstone Partners’ Consumer Investment Banking Team provides M&A, capital formation, and financial advisory services to the owners of middle market businesses in the consumer and retail industries. Our team partners with leading mid-to-large sized consumer businesses that serve growing end-markets. For more information on the Vitamins & Supplements M&A trends featured in this report or to speak with one of our Consumer Investment Banking Team members about how to grow, value, and/or sell your company, we are here to help. Contact us today to start a conversation.

Related Transactions

Insights for Middle Market Leaders

Receive email updates with our proprietary data, reports, and insights as they’re published for the industries that matter to you most.